164 related articles for article (PubMed ID: 24036035)
1. Proteomic analysis of Mycobacterium tuberculosis isolates resistant to kanamycin and amikacin.
Kumar B; Sharma D; Sharma P; Katoch VM; Venkatesan K; Bisht D
J Proteomics; 2013 Dec; 94():68-77. PubMed ID: 24036035
[TBL] [Abstract][Full Text] [Related]
2. Comparative Proteomic Analysis of Aminoglycosides Resistant and Susceptible Mycobacterium tuberculosis Clinical Isolates for Exploring Potential Drug Targets.
Sharma D; Kumar B; Lata M; Joshi B; Venkatesan K; Shukla S; Bisht D
PLoS One; 2015; 10(10):e0139414. PubMed ID: 26436944
[TBL] [Abstract][Full Text] [Related]
3. Proteome analysis of ofloxacin and moxifloxacin induced mycobacterium tuberculosis isolates by proteomic approach.
Lata M; Sharma D; Kumar B; Deo N; Tiwari PK; Bisht D; Venkatesan K
Protein Pept Lett; 2015; 22(4):362-71. PubMed ID: 25666036
[TBL] [Abstract][Full Text] [Related]
4. M. tuberculosis ferritin (Rv3841): Potential involvement in Amikacin (AK) & Kanamycin (KM) resistance.
Sharma D; Lata M; Faheem M; Khan AU; Joshi B; Venkatesan K; Shukla S; Bisht D
Biochem Biophys Res Commun; 2016 Sep; 478(2):908-12. PubMed ID: 27521892
[TBL] [Abstract][Full Text] [Related]
5. Discordant resistance to kanamycin and amikacin in drug-resistant Mycobacterium tuberculosis.
Krüüner A; Jureen P; Levina K; Ghebremichael S; Hoffner S
Antimicrob Agents Chemother; 2003 Sep; 47(9):2971-3. PubMed ID: 12937004
[TBL] [Abstract][Full Text] [Related]
6. Cytosolic Proteome Profiling of Aminoglycosides Resistant
Sharma D; Lata M; Singh R; Deo N; Venkatesan K; Bisht D
Front Microbiol; 2016; 7():1816. PubMed ID: 27895634
[TBL] [Abstract][Full Text] [Related]
7. Proteomic analysis of ofloxacin-mono resistant Mycobacterium tuberculosis isolates.
Lata M; Sharma D; Deo N; Tiwari PK; Bisht D; Venkatesan K
J Proteomics; 2015 Sep; 127(Pt A):114-21. PubMed ID: 26238929
[TBL] [Abstract][Full Text] [Related]
8. Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables.
Kambli P; Ajbani K; Nikam C; Sadani M; Shetty A; Udwadia Z; Georghiou SB; Rodwell TC; Catanzaro A; Rodrigues C
Int J Mycobacteriol; 2016 Mar; 5(1):1-6. PubMed ID: 26927983
[TBL] [Abstract][Full Text] [Related]
9. Proteomic analysis of drug-resistant Mycobacterium tuberculosis by one-dimensional gel electrophoresis and charge chromatography.
Yari S; Hadizadeh Tasbiti A; Ghanei M; Shokrgozar MA; Fateh A; Mahdian R; Yari F; Bahrmand A
Arch Microbiol; 2017 Jan; 199(1):9-15. PubMed ID: 27417316
[TBL] [Abstract][Full Text] [Related]
10. Secretory Proteome Analysis of Streptomycin-Resistant Mycobacterium tuberculosis Clinical Isolates.
Sharma D; Bisht D
SLAS Discov; 2017 Dec; 22(10):1229-1238. PubMed ID: 28314116
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of the chromosomally encoded aminoglycoside acetyltransferase eis confers kanamycin resistance in Mycobacterium tuberculosis.
Zaunbrecher MA; Sikes RD; Metchock B; Shinnick TM; Posey JE
Proc Natl Acad Sci U S A; 2009 Nov; 106(47):20004-9. PubMed ID: 19906990
[TBL] [Abstract][Full Text] [Related]
12. High level of cross-resistance between kanamycin, amikacin, and capreomycin among Mycobacterium tuberculosis isolates from Georgia and a close relation with mutations in the rrs gene.
Jugheli L; Bzekalava N; de Rijk P; Fissette K; Portaels F; Rigouts L
Antimicrob Agents Chemother; 2009 Dec; 53(12):5064-8. PubMed ID: 19752274
[TBL] [Abstract][Full Text] [Related]
13. Comparative proteomic analysis of sequential isolates of Mycobacterium tuberculosis sensitive and resistant Beijing type from a patient with pulmonary tuberculosis.
Singh A; Gupta AK; Gopinath K; Sharma D; Sharma P; Bisht D; Sharma P; Singh S
Int J Mycobacteriol; 2016 Dec; 5 Suppl 1():S123-S124. PubMed ID: 28043501
[TBL] [Abstract][Full Text] [Related]
14. Comparison of clinical isolates and in vitro selected mutants reveals that tlyA is not a sensitive genetic marker for capreomycin resistance in Mycobacterium tuberculosis.
Engström A; Perskvist N; Werngren J; Hoffner SE; Juréen P
J Antimicrob Chemother; 2011 Jun; 66(6):1247-54. PubMed ID: 21427106
[TBL] [Abstract][Full Text] [Related]
15. Prediction of Mycobacterium tuberculosis drug resistance by nucleotide MALDI-TOF-MS.
Wu X; Tan G; Yang J; Guo Y; Huang C; Sha W; Yu F
Int J Infect Dis; 2022 Aug; 121():47-54. PubMed ID: 35523300
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of eis without a mutation in promoter region of amikacin- and kanamycin-resistant Mycobacterium tuberculosis clinical strain.
Sowajassatakul A; Prammananan T; Chaiprasert A; Phunpruch S
Ann Clin Microbiol Antimicrob; 2018 Jul; 17(1):33. PubMed ID: 30008266
[TBL] [Abstract][Full Text] [Related]
17. Proteomic analysis of streptomycin resistant and sensitive clinical isolates of Mycobacterium tuberculosis.
Sharma P; Kumar B; Gupta Y; Singhal N; Katoch VM; Venkatesan K; Bisht D
Proteome Sci; 2010 Nov; 8():59. PubMed ID: 21083941
[TBL] [Abstract][Full Text] [Related]
18. Molecular and phenotypic characterization of multidrug-resistant Mycobacterium tuberculosis isolates resistant to kanamycin, amikacin, and capreomycin in China.
Zhang Z; Liu M; Wang Y; Pang Y; Kam KM; Zhao Y
Eur J Clin Microbiol Infect Dis; 2014 Nov; 33(11):1959-66. PubMed ID: 24906439
[TBL] [Abstract][Full Text] [Related]
19. Comparative proteomic analysis of sequential isolates of Mycobacterium tuberculosis from a patient with pulmonary tuberculosis turning from drug sensitive to multidrug resistant.
Singh A; Gopinath K; Sharma P; Bisht D; Sharma P; Singh N; Singh S
Indian J Med Res; 2015 Jan; 141(1):27-45. PubMed ID: 25857493
[TBL] [Abstract][Full Text] [Related]
20. Molecular Investigation of Resistance to Second-Line Injectable Drugs in Multidrug-Resistant Clinical Isolates of Mycobacterium tuberculosis in France.
Brossier F; Pham A; Bernard C; Aubry A; Jarlier V; Veziris N; Sougakoff W;
Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27895017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
